Showing results (71-80 of 697) with videos related to
Sort By:
Pageof 70
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 13, 1998
Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in womenB Janand-Delenne, C Chagnaud, D Raccah, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood levelP E Morange, M C Alessi, M Verdier, et al.Angiology|November 1, 1978
Treatment of venous thrombosis and pulmonary embolism by streptokinaseA Serradimigni, M Bory, P Djiane, et al.Thrombosis and Haemostasis|June 30, 1989
Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulinI Juhan-Vague, C Roul, M C Alessi, et al.Annales De Biologie Clinique|January 1, 1988
[The significance of the levels of D-dimer in thrombotic conditions]C Roul, M F Aillaud, A Elias, et al.Circulation|August 5, 1997
Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levelsW L Chandler, M C Alessi, M F Aillaud, et al.Journal of Lipid Research|January 1, 1993
Phosphatidylinositol turnover during stimulation of plasminogen activator inhibitor-1 secretion induced by oxidized low density lipoproteins in human endothelial cellsM Chautan, Y Latron, F Anfosso, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cellsY Latron, M Chautan, F Anfosso, et al.Human Genetics|August 21, 2001
Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphismsD A Trégouet, H Aubert, M Henry, et al.Blood|January 1, 1996
Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937F Peiretti, C Fossat, F Anfosso, et al.Pageof 70